ArticleObesity surgery2025
Recurrent Weight Gain after Sleeve Gastrectomy: Is Conversion to Duodenal Switch Superior to Roux-en-Y Gastric Bypass?
Article in Obesity surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Post-sleeve gastrectomy weight loss: Role of botulinum toxin and semaglutide injections.Endoscopy international open · 2026Article
- Surgical management of marginal ulcer sequelae after Roux-en-Y gastric bypass: a single-center retrospective cohort study.Surgical endoscopy · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRates of conversion procedures after Sleeve Gastrectomy have been reported to reach up to 12.2% in 10 years of follow-up. The aim of this study was to compare perioperative outcomes and weight changes in patients who underwent either conversion from SG to Roux-en-Y Gastric Bypass (C-RYGB) or Duodenal Switch (C-DS).
methodsThis study was a nonrandomized, controlled, retrospective review of 100 patients who underwent conversion of LSG due to recurrent weight gain at our institution from May 2015 to November 2024. Perioperative and postoperative variables were examined.
resultsOf 481 SGs, 100 patients (90 C-RYGB; 10 C-DS) underwent conversion due to recurrent weight gain. The C-DS group had a higher preoperative BMI compared to C-RYGB (57.2 kg/m
conclusionsC-DS appears to be safe and feasible for the surgical management of recurrent weight gain after LSG. In addition, C-DS provides a significantly higher %TWL on 6, 12 and 24 months compared to C-RYGB.
Indexed as
Identifiers
41108365What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.